Monica M. Bertagnolli, MD

Articles by Monica M. Bertagnolli, MD

Controversies in the Surgical Management of GIST in the Era of Imatinib

ByChandrajit P. Raut, MD, MSc,Monica M. Bertagnolli, MD

January 2nd 2009

In the pre-imatinib era, surgery was the only effective treatment for gastrointestinal stromal tumor (GIST). However, this treatment modality was often either not possible or insufficient for cure due to the aggressive nature of this disease.

Latest Updated Articles

Controversies in the Surgical Management of GIST in the Era of Imatinib
January 2nd 2009

Trending on CancerNetwork

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors

FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma

119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)